Pharmaceutical Technology

JUNE 26, 2025

A month and a half after winding operations and laying off almost all its staff, Vor Bio has emerged from the brink with a licensing deal potentially rising to $4bn for an autoimmune drug developed by Chinese biotech RemeGen. The deal signals an abrupt turnaround for Vor Bio.

Packaging 52

Packaging Communication Hospitals Drug Development 52

Pharmaceutical Technology

JUNE 19, 2025

Then, we will need to run pre-clinical trials of these crystals, which will be in 2026 or 2027. Then the next step is to produce meaningful quantities of these crystals, which will be next year.” After that, it will be about compliance and regulation, as we must ensure that all our processes adhere to pharma regulations.

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

JUNE 25, 2025

The European Commission (EC) faces a March 2027 deadline to adopt several key implementing acts, which will lay out detailed rules for putting the regulation into practice. The regulation came into force in March 2025; however, it has not yet come into application, with this set to happen in March 2029.

Communication 52

Communication Hospitals Packaging Pharmaceutical Companies 52

European Pharmaceutical Review

FEBRUARY 7, 2023

Launch of the EU pharmaceutical package The European Commission plans to commence initiatives relating to the European Pharmaceutical Strategy (strategy) with the publication of the revised EU pharmaceutical package scheduled during the first quarter of 2023. of the MDR and Article 110.4

Packaging 117

Packaging Drug Development 117

pharmaphorum

JANUARY 18, 2022

million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. Who should Attend: Drug-delivery developers. Primary Packaging material designers. Secondary packagers. Smart device developers. Training device developers. Drug developers.

Packaging 52

Packaging Documentation Drug Development Vaccines 52